最後更新 2024-11-21 16:31:21 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

7.7%


截至2024-09-30

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

利格生物公司在北美、歐洲、亞太地區以及國際上開發和商業化生物加工技術和系統,用於生物藥品製造過程。它提供蛋白A配體,這些是蛋白A親和層析樹脂的結合組分;以及細胞培養生長因子產品。該公司的層析產品包括OPUS預填充層析柱,用於生物製品的純化;以及用於高通量工藝開發篩選、病毒清除驗證研究和層析工藝縮小驗證的OPUS小型柱。它還提供ELISA試劑盒;以及CaptivA品牌的層析樹脂。此外,該公司提供過濾產品,如XCell交替切向流系統,這是用於上游灌注和細胞培養加工的過濾設備;TangenX平板式膜盒,用於下游生物藥品濃縮和配方過程;KrosFlo切向流過濾和切向流深度過濾系統;Spectra/Por實驗室和工藝透析產品,以及SpectraFlo動態透析系統;以及ProConnex一次性中空纖維。此外,它還提供過程分析產品,如SoloVPE、FlowVPE和FlowVPX品牌下的斜率光譜儀系統。該公司將產品銷售給生命科學、生物製藥和診斷公司;實驗室研究人員;以及合同製造組織。利格生物公司與Navigo Proteins GmbH有合作協議,共同開發多種親和力配體。利格生物公司成立於1981年,總部位於馬薩諸塞州沃爾瑟姆。



Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

所屬產業

所屬類股
Healthcare
所屬產業
Medical - Instruments & Supplies

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning